Based on the Accelerate Diagnostics Inc stock forecast from 0 analysts, the average analyst target price for Accelerate Diagnostics Inc is not available over the next 12 months. Accelerate Diagnostics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Accelerate Diagnostics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Accelerate Diagnostics Inc’s stock price was USD 1.14. Accelerate Diagnostics Inc’s stock price has changed by +7.55% over the past week, -5.00% over the past month and +8.57% over the last year.
No recent analyst target price found for Accelerate Diagnostics Inc
No recent average analyst rating found for Accelerate Diagnostics Inc
Company Overview Accelerate Diagnostics Inc
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. Read Less
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and anti...Read More
Frequently Asked Questions About Accelerate Diagnostics Inc (AXDX) Stock
Stock Target Advisor's fundamental analysis for Accelerate Diagnostics Inc's stock is Bearish.
Unfortunately we do not have enough data on AXDX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AXDX's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on AXDX's stock to indicate if its overvalued.
The last closing price of AXDX's stock was USD 1.14.
The most recent market capitalization for AXDX is USD 0.03B.
Unfortunately we do not have enough analyst data on AXDX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Accelerate Diagnostics Inc's stock.
As per our most recent records Accelerate Diagnostics Inc has 134 Employees.
Accelerate Diagnostics Inc's registered address is 3950 South Country Club Road, Tucson, AZ, United States, 85714.
You can get more information about it from Accelerate Diagnostics Inc's website at https://acceleratediagnostics.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Accelerate Diagnostics Inc (AXDX) Stock
Stock Target Advisor's fundamental analysis for Accelerate Diagnostics Inc's stock is Bearish.
Unfortunately we do not have enough data on AXDX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on AXDX's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on AXDX's stock to indicate if its overvalued.
The last closing price of AXDX's stock was USD 1.14.
The most recent market capitalization for AXDX is USD 0.03B.
Unfortunately we do not have enough analyst data on AXDX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Accelerate Diagnostics Inc's stock.
As per our most recent records Accelerate Diagnostics Inc has 134 Employees.
Accelerate Diagnostics Inc's registered address is 3950 South Country Club Road, Tucson, AZ, United States, 85714.
You can get more information about it from Accelerate Diagnostics Inc's website at https://acceleratediagnostics.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AXDX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
